Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Net Income (2016 - 2025)

Neuroone Medical Technologies' Net Income history spans 14 years, with the latest figure at -$1.4 million for Q4 2025.

  • For Q4 2025, Net Income fell 180.54% year-over-year to -$1.4 million; the TTM value through Dec 2025 reached -$6.8 million, up 5.0%, while the annual FY2025 figure was -$3.6 million, 70.73% up from the prior year.
  • Net Income reached -$1.4 million in Q4 2025 per NMTC's latest filing, up from -$1.6 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $1.8 million in Q4 2024 to a low of -$3.5 million in Q1 2023.
  • Average Net Income over 5 years is -$2.4 million, with a median of -$2.8 million recorded in 2022.
  • Peak YoY movement for Net Income: soared 153.37% in 2024, then plummeted 180.54% in 2025.
  • A 5-year view of Net Income shows it stood at -$2.8 million in 2021, then skyrocketed by 38.28% to -$1.7 million in 2022, then tumbled by 93.04% to -$3.3 million in 2023, then skyrocketed by 153.37% to $1.8 million in 2024, then tumbled by 180.54% to -$1.4 million in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Net Income are -$1.4 million (Q4 2025), -$1.6 million (Q3 2025), and -$1.5 million (Q2 2025).